Michael J Rossi
CIK 1948795 · PRESIDENT & CEO · last filed 2025-09-18
Michael J Rossi is a PRESIDENT & CEO who has filed 8 SEC Form 4 insider transactions across 2 companies since 2022. Across all open-market trades the lifetime net is −$20.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
8
-$20.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | PRESIDENT & CEO | 137,083 | $8.61 | $1.18M | -$20.4K | 4 | 2025-03-11 |
| Mirion Technologies, Inc. (MIR.WS) Delisted | Medical Group President | 116,173 | $2.16 | $250.9K | $0 | 3 | 2023-11-03 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-18 | — | Mixed | −137,083 | -$68.6K | |
| 2025-03-11 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Sell (S) | −3,917 | -$20.4K | EDGAR |
| 2025-01-22 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +105,300 | $0 | EDGAR |
| 2024-02-14 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +35,700 | $0 | EDGAR |
| 2023-11-08 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-03 | Mirion Technologies, Inc. (MIR.WS) Delisted | Tax (F) | −5,514 | -$38.2K | EDGAR |
| 2023-03-31 | Mirion Technologies, Inc. (MIR.WS) Delisted | Grant (A) | +41,242 | $0 | EDGAR |
| 2022-11-03 | Mirion Technologies, Inc. (MIR.WS) Delisted | Grant (A) | +80,445 | $0 | EDGAR |